Log in
Log in
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     


Delayed Nyse  -  04:00:02 2023-06-09 pm EDT
160.01 USD   -0.16%
06/08Johnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong, 2022 DEI Impact Review
06/08Johnson & Johnson Releases 2022 Health for Humanity Report Demonstrating Progress Against Goals
06/08Johnson & Johnson Health Care Systems Gets Up to $47.3 Million US Defense Logistics Agency Contract
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : Boers offering free Covid-19 jabs to seafarers

08/11/2021 | 08:29am EDT

Crew services specialist Boers has launched seafarer vaccination programmes at German and Belgian ports, as shipping executives warn of onboard Covid-19 outbreaks because mariners are not getting vaccines quick enough.

Seafarers arriving at ports in Antwerp, Ghent and Zeebrugge can get one-shot Covid-19 jabs through Boers' scheme, which is being launched to protect key workers in the shipping industry.

The Janssen (Johnson & Johnson) vaccine will be available free of charge until further notice to all mariners of any nationality arriving in Belgium for crew changes. There is a fee for the medical services provided by the port authorities.

"Getting as many seafarers as possible vaccinated is absolutely vital to supply chains and global markets," said Hans Boers, Co-CEO of Boers, the Netherlands-based shipping crew transport services operator for Northern Europe.

"We've seen with the crew change crisis the challenges shipping companies face in hiring seafarers for their vessels, creating a shortage of available mariners which in turn has led to rising prices for goods, food and petrol as demand outstrips supply.

"For us, the most important thing is making sure crew members entering Belgian ports have access to free Covid-19 jabs. Protecting seafarers from the virus is paramount - and we have the means to help do that. The more mariners who have the vaccine, the quicker shipping and life in general can return to normal."

Boers recently began offering free jabs to mariners at German ports in Hamburg and Bremerhaven. The company also provides vaccinations at ports in the Netherlands, albeit for just Dutch flagged or owned vessels but it plans to extend this service to all seafarers.

While Boers is supporting efforts to vaccinate all seafarers, maritime executives such as Esben Poulsson, Chairman of the International Chamber of Shipping, say the new delta strain of Covid-19 has hampered the shipping industry.

Poulsson added that crew changes were not happening quickly enough to satisfy increased demand for products, especially from the US and Europe in the lead up to Christmas, putting more pressure on already strained global supply chains. He also criticised government figures for continuing to stick their heads in the sand.

Stephen Cotton, general secretary, International Transport Workers' Federation, expressed similar concerns about the crew change crisis. "The situation is going from bad to worse," he said. "We need more than lip service from governments; we need concrete action that allows crew changes to be carried out in a safe manner."

Meanwhile, IMO Secretary-General Kitack Lim has urged IMO member states to support a fair global distribution of Covid-19 vaccines, to ensure seafarers have access to jabs.

"No seafarers should be left behind or forced to forgo their careers because of limited resources in their home country," Lim said. He added that shipping companies needed to provide testing, appropriate PPE and access to medical and sanitation facilities, to protect crew members and prevent the virus spreading.

At Belgian ports, seafarers who want the Covid-19 vaccine must apply at least 48 hours before their ship is berthed. Application forms, which should include the vessel information, expected time of arrival and details of the mariner wanting the vaccination, must be sent to info@boers-crewservices.nl.

On receiving the application, the port's maritime medical centre will either confirm or refuse the request. Vaccinations on vessels are available for five or more crew members, with groups of four or less having to go to the medical centre. Any Covid-19 jab will be recorded in the seafarer's vaccination booklet.

In Germany, Boers offers around 30 shots on Tuesdays and Thursdays and approximately 40 shots on Saturdays to seafarers at Hamburg's port. Details for the number of vaccines available in Bremerhaven and on what days are being finalised.

Shipping companies that want vaccines for their seafarers at German ports need to provide Boers with a crew list, vaccination passport, the vessel's contact details and a patient agreement and information sheet signed by the crew member.

For more details, call +(0)3110 415 7725 or email info@boers-crewservices.nl


For more information please contact:

Lisa Jacobs, Elaborate Communications +44 (0)1296 682104

Rob Morris, Elaborate Communications +44 (0)1296 682089

About Boer Crew Services:

Established in 1946, Boers Crew Services is a crew change specialist, unburdening its clients through local knowledge of immigration rules and maritime infrastructure. The company handles all travel and logistical requirements for seafarers, such as providing taxi services to and from ports, arranging letters of indemnity, visas on arrival, hotel bookings, pandemic services and Dutch documents. A 24/7 consistent, comprehensive, and cooperative maritime service provided by a competent and experienced staff.


(C) 2021 M2 COMMUNICATIONS, source M2 PressWIRE

All news about JOHNSON & JOHNSON
06/08Johnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong, 2022 ..
06/08Johnson & Johnson Releases 2022 Health for Humanity Report Demonstrating Progress Again..
06/08Johnson & Johnson Health Care Systems Gets Up to $47.3 Million US Defense Logistics Age..
06/07Johnson & Johnson : Janssen Submits Supplemental Biologics License Application to U.S. FDA..
06/07Indices: Flight to quality
06/07Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval..
06/06Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
06/06Johnson & Johnson Submits Supplemental Biologics License Application to U.S. FDA Seekin..
06/06Alkermes Gets Final Award in Janssen Pharmaceutica Arbitration; 2023 Adjusted EPS, Reve..
06/06Advancing Multiple Shots On Clinical Goals, Coeptis Therapeutics Positions For A Busy V..
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2023 98 893 M - -
Net income 2023 19 083 M - -
Net Debt 2023 7 795 M - -
P/E ratio 2023 21,5x
Yield 2023 2,94%
Capitalization 448 B 448 B -
EV / Sales 2023 4,61x
EV / Sales 2024 4,30x
Nbr of Employees 152 700
Free-Float 83,2%
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 160,01 $
Average target price 179,20 $
Spread / Average Target 12,0%
EPS Revisions
Managers and Directors
Joaquin Duato Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Matthew Stuckley Senior Financial Analyst-Janssen Commercial Pharm
James D. Swanson Global Chief Information Officer & Executive VP
Ahmet Tezel Global Head-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON-9.28%447 623
NOVO NORDISK A/S17.16%356 555
MERCK & CO., INC.-0.22%279 930
ROCHE HOLDING AG-2.25%254 900
ABBVIE INC.-14.50%242 837
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration